TCL Archive ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures March 29, 1985
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive New Cancer Control Approaches May Include CCRU RFA, Center Cooperative Groups, Regional “Rounds” March 18, 1983
